New drug may offer hope for Parkinson’s disease February 2011
MHRI Researchers have been evaluating novel compounds supplied by partners at Prana Biotechnology to identify a disease-modifying drug for Parkinson’s disease. A promising candidate has been selected for further investigation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.